Hims & Hers Health, Inc. (HIMS) is scheduled to report second-quarter 2024 results on Aug 5, after the closing bell.In the last reported quarter, the company’s earnings per share (EPS) of 5 cents surpassed the Zacks Consensus Estimate by 150%. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on three occasions and missed once, delivering an earnings surprise of 79.2%, on average.For second-quarter 2024, the Zacks Consensus Estimate for revenues is pegged at $304.7 mill ...